Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 24:28:e937112.
doi: 10.12659/MSM.937112.

Risk Factors and Pathogen Spectrum in Continuous Ambulatory Peritoneal Dialysis-Associated Peritonitis: A Single Center Retrospective Study

Affiliations

Risk Factors and Pathogen Spectrum in Continuous Ambulatory Peritoneal Dialysis-Associated Peritonitis: A Single Center Retrospective Study

Supei Yin et al. Med Sci Monit. .

Abstract

BACKGROUND To investigate the incidence, risk factors, pathogen distribution, and drug resistance patterns in continuous ambulatory peritoneal dialysis-associated peritonitis (CAPDP). MATERIAL AND METHODS Clinical data for 248 patients who underwent continuous ambulatory peritoneal dialysis (CAPD) treatment in a single center in China from March 2018 to January 2021 were retrospectively collected. The patients were divided into the CAPDP group (n=40) and the non-CAPDP group (n=208) according to whether peritonitis occurred. The incidence rate, risk factors, bacterial distribution, and drug sensitivity of CAPDP were analyzed. RESULTS The incidence of CAPDP was 16.13%, and 87.5% of patients with CAPDP continued CAPDP treatment after anti-infection treatment. Patients with and without CAPDP were clearly distinguished, on the basis of their clinical characteristics, by using principal component analysis (PCA) methods. Logistic regression analysis found that body mass index (BMI; P=0.0095), albumin (P=0.016), albumin/globulin ratio (P=0.018), C-reactive protein (P=0.0001), and rapid transport (P=0.034) were independent risk factors for CAPDP. The main pathogens causing the CAPDP were Staphylococcus epidermidis (50.00%), Staphylococcus capitis (13.33%), and Escherichia coli (10.00%). Among the pathogenic bacteria, the main drugs to which gram-negative cocci were sensitive were imipenem, meropenem, piperacillin/tazobactam, cefoperazone/sulbactam, ceftazidime, and tigecycline. The main drugs to which gram-positive cocci were sensitive were vancomycin, teicoplanin, and linezolid. The drug resistance rate of pathogenic bacteria to penicillin G, ampicillin, compound trimethoprim, cefepime, ceftriaxone, and amoxicillin-clavulanic acid drugs was 36.26-100%. CONCLUSIONS BMI, albumin, albumin/globulin ratio, C-reactive protein, and rapid transport are independent risk factors for CAPDP. Gram-positive bacteria are the main pathogens of CAPDP and are sensitive to vancomycin, teicoplanin, and linezolid.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

Figures

Figure 1
Figure 1
Principal component analysis (PCA) of clinical characteristics between patients with peritoneal dialysis-associated peritonitis (PDAP) and without PDAP.
Figure 2
Figure 2
(A) Mean decrease in accuracy in predicting the occurrence of peritoneal dialysis-associated peritonitis (PDAP) when using the random forest model. (B) Mean decrease in the Gini coefficient in predicting the occurrence of PDAP when using the random forest model. (C) The results of the receiver operating characteristic curve (ROC) analysis, using random forest prediction value to detect the occurrence of PDAP.

Similar articles

Cited by

References

    1. Li PK, Chow KM, Van de Luijtgaarden MW, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2016;13(2):90–103. - PubMed
    1. Woodrow G, Fan SL, Reid C, et al. Renal association clinical practice guideline on peritoneal dialysis in adults and children. BMC Nephrol. 2017;18(1):333. - PMC - PubMed
    1. Jeloka TK, Abraham G, Bhalla AK, et al. Continuous ambulatory peritoneal dialysis peritonitis guidelines-consensus statement of Peritoneal Dialysis Society of India-2020. Indian J Nephrol. 31(5):425–34. 202. - PMC - PubMed
    1. Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl. 2006;10(3):S55–62. - PubMed
    1. Salzer WL. Peritoneal dialysis-related peritonitis: challenges and solutions. Int J Nephrol Renovasc Dis. 2018;11(2):173–86. - PMC - PubMed